O
PRTA icon

OppenheimerFunds’s Prothena Corp PRTA Stock Holding History

OppenheimerFunds’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-168,291
Closed -$10.9M – 1866
2017
Q3 		$10.9M Sell
168,291
-215
-0.1% -$13.2K 0.01% 728
2017
Q2 		$9.12M Sell
168,506
-54
-0% -$2.88K 0.01% 757
2017
Q1 		$9.4M Buy
168,560
+780
+0.5% +$41K 0.01% 773
2016
Q4 		$8.25M Hold
167,780
– – 0.01% 780
2016
Q3 		$10.1M Buy
167,780
+930
+0.6% +$49.9K 0.01% 733
2016
Q2 		$5.83M Buy
166,850
+59,185
+55% +$2.58M 0.01% 791
2016
Q1 		$4.43M Buy
+107,665
New +$4.21M 0.01% 823

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds's PRTA Position: Q4 2017 in Review

OppenheimerFunds sold out of Prothena Corp (PRTA) in Q4 2017, closing a stake of 168,291 shares — an estimated $10.9M sold.

OppenheimerFunds first reported a position in PRTA in Q1 2016 and held it in 7 quarters. The position peaked at $10.9M in Q3 2017. 155 funds tracked by Wall St. Rank hold PRTA as of Q4 2017.

  • OppenheimerFunds reported no remaining Prothena Corp position as of Q4 2017 after selling out during the quarter.
  • OppenheimerFunds sold 168,291 Prothena Corp shares in Q4 2017, an estimated $10.9M.
  • OppenheimerFunds first reported a position in Prothena Corp in Q1 2016 and held it in 7 quarters.
  • OppenheimerFunds's Prothena Corp position peaked at $10.9M in Q3 2017.
  • 155 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2017.

Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.